If you’re checking your portfolio over coffee, here’s the scoop: Microchip Technology just beat its own sales forecast, sending its stock up over 3% after hours. Meanwhile, AngioDynamics is bracing for a loss, and Galapagos is ditching its cell therapy biz (which actually boosted its shares). For everyday investors, this is a reminder—one earnings update can move your stocks overnight, so keep an eye on those after-hours headlines! #Business #Market #stocks